Health ❯ Medical Research

Gene Therapy

Clinical Trials Genetic Disorders Huntington's Disease Personalized Medicine Gene Editing Duchenne Muscular Dystrophy Cardiovascular Health Ophthalmology CRISPR Technology Phage Therapy Hearing Impairment Pediatric Gene Therapy Neurological Disorders Neurodegenerative Diseases Congenital Deafness Neuroscience Hearing Disorders CRISPR Applications AAV Vectors Immunotherapy AFM-Téléthon Sarepta Therapeutics mRNA Technology Cardiomyopathy Regenerative Medicine Cardiovascular Disease HIV Gene Therapy Adeno-Associated Virus (AAV) Cancer Research Targeted Therapies Clinical Evaluation Infectious Diseases Gene Silencing Genetic Modifications Genome Editing Techniques Acoustic Stimulation Hearing Restoration Biotechnology Tumor Angiogenesis Targeted Delivery Systems OTOF Gene Therapy Quality Control DNA Repair Mucopolysaccharidosis Type I Cytokine Research Liver Diseases RNA Interference (RNAi) Diabetic Kidney Disease Delivery Systems siRNA Therapy Targeted Therapy Retinal Diseases Cystic Fibrosis Genetic Engineering RNA Interference mRNA Vaccines Inherited Disorders MicroRNA Treatments Neurological Diseases Gene Manipulation Viral Vectors Sickle Cell Disease Inherited Conditions Antisense Oligonucleotides Cell Therapy Hearing Loss Heart Failure X-SCID Treatment Funding Challenges MicroRNA OTOF Gene Therapeutic Applications Epigenetic Editing Blood Disorders Non-Viral Techniques Safety Testing Cancer Treatment MicroRNA Applications

CRISPR Enzyme Cas12a2 Selectively Destroys Cells Based on RNA in Lab Tests

Translation hinges on animal studies followed by practical delivery to specific tissues.

Engineered Mini CRISPR Achieves Up to 90% Editing in Human Cells

REGENXBIO Investors Face April 14 Deadline to Seek Lead Role in RGX-111 Securities Suit

Sarepta Reports 3-Year EMBARK Data Showing Elevidys Slows Duchenne Progression

Lilly Licenses MeiraGTx Eye Gene Therapy in Deal Worth Up to $475 Million

Gene Therapy Shows 75% Slower Huntington’s Decline in Early Trial

uniQure Gene Therapy Shows 75% Slowing of Huntington’s in Early Trial

Gene Therapy Slows Huntington’s Progression by 75% in Early Trial, uniQure Says

AI Designs Functional Bacteriophage Genomes That Kill E. Coli

Researchers Debut Three Precision Gene Editing Tools Reducing Damage and Off-Target Errors

David Baltimore, Nobel Laureate Who Discovered Reverse Transcriptase, Dies at 87

DNA-Coated Nanoparticles Triple CRISPR Editing in Lab Tests

Small Subset of Newborn Liver Cells Drives Growth, Recasting Pediatric Gene Therapy Timing

Yale’s ChronODE Pinpoints Gene Activation Windows in the Developing Brain

Kidney Organoids Reveal NFκB‑Linked AAV2 Toxicity, With Bardoxolone Methyl Mitigating Damage

AI-Guided Pythia Steers CRISPR Edits Toward Precise DNA Integration

Single Birth Injection Protects Primates From HIV, Paves Way for Newborn Safety Trials

Active Interstellar Comet 3I/ATLAS Set for Safe Solar System Passage

AAV-OTOF Gene Therapy Restores Hearing in Teens and Adults

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion